Publication | Open Access
Clinical Implications of Claudin18.2 Expression in Patients With Gastric Cancer
77
Citations
15
References
2019
Year
Higher expression of CLDN18.2 was observed in diffuse-type and HER2-positive gastric cancers. Meanwhile, CLDN18.2 expression was not associated with survival in patients with gastric cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1